Queen’s University Wins €23.3m from the Innovative Medicines Initiative (IMI) programme to develop new antibiotic treatments for cystic fibrosis and bronchiectasis

  Researchers at Queen’s are leading a €50 million, Europe-wide, project to develop new drug treatments that could improve the lives of patients with cystic fibrosis and bronchiectasis. The iABC (inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis) consortium, which is made up of world-leading lung specialists from across Europe, will develop new ‘inhaled antibiotics’ to […]

View Post